Skip to main content

A Framework for Equitable Allocation of Vaccine for the Novel Coronavirus

Completed

Despite the worldwide effort to develop safe and effective vaccines against COVID-19 and ramp up production capacity, it is inevitable that initial vaccine supply will be limited. Therefore, policymakers must develop plans to ensure the equitable allocation of limited doses until there is sufficient global supply.

In response to a request from the National Institutes of Health (NIH) and Centers for Disease Control and Prevention (CDC), the National Academies have formed a committee that will produce a consensus study to assist policymakers in the U.S. and global health communities in planning for equitable allocation of vaccines against COVID-19.

News and updates

Showing 1–9 of 9 items
Sort by:
Subscribe to Emails from the National Academies
Stay up to date on activities, publications, and events by subscribing to email updates.